Vivesto AB Sustainability Reports
Vivesto AB is a drug development company focusing on offering new treatment options for hard-to-treat cancers where there are major medical needs. The company operates a proprietary drug delivery platform targeting both human oncology therapeutics and veterinary treatments.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 5493003TZPR4B7QO9L49
4 reports from 2021 to 2025